Cargando…

Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival

BACKGROUND: Evidences about survival of the patients with head and neck squamous cell carsinoma (HNSCC) have been scant in our region. OBJECTIVES: The aim of current study was to determine clinico-pathological and treatment-related factors, influencing outcome of these patients. PATIENTS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Novin, Kambiz, Ameri, Ahmad, Faraji, Saba, Torbati, Peyman, Mortazavi, Nafiseh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667237/
https://www.ncbi.nlm.nih.gov/pubmed/26634109
http://dx.doi.org/10.17795/ijcp-3842
_version_ 1782403807453380608
author Novin, Kambiz
Ameri, Ahmad
Faraji, Saba
Torbati, Peyman
Mortazavi, Nafiseh
author_facet Novin, Kambiz
Ameri, Ahmad
Faraji, Saba
Torbati, Peyman
Mortazavi, Nafiseh
author_sort Novin, Kambiz
collection PubMed
description BACKGROUND: Evidences about survival of the patients with head and neck squamous cell carsinoma (HNSCC) have been scant in our region. OBJECTIVES: The aim of current study was to determine clinico-pathological and treatment-related factors, influencing outcome of these patients. PATIENTS AND METHODS: We have reviewed all patients with a new diagnosis of HNSCC admitted between 2008 and 2014 in “Jorjani Cancer Center”, Tehran, Iran. Overall survival (OS) and event free survival (EFS) of the patients, and their relation with demographic and clinico-pathological factors have been analyzed. RESULTS: Among 119 included patients, 90 were male and 29 were female with mean age of 58 years. Larynx was the most common primary tumor site (55% of all patients). With a median follow-up period of 28 months, OS and EFS of the study patients was 61.2% and 52.4%, respectively. Tumor stage was the only parameter has significantly influenced the patients’ OS. Patients with normal BMIs had significantly higher mean EFS compared with patients with bellow or above normal BMIs. Surgical treatment modalities have resulted in the same prognosis as non-surgical approaches. CONCLUSIONS: Our study seems to be the first that investigated outcome of Iranian patients with head and neck cancer and its influencing factors.
format Online
Article
Text
id pubmed-4667237
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Shahid Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-46672372015-12-02 Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival Novin, Kambiz Ameri, Ahmad Faraji, Saba Torbati, Peyman Mortazavi, Nafiseh Iran J Cancer Prev Research Article BACKGROUND: Evidences about survival of the patients with head and neck squamous cell carsinoma (HNSCC) have been scant in our region. OBJECTIVES: The aim of current study was to determine clinico-pathological and treatment-related factors, influencing outcome of these patients. PATIENTS AND METHODS: We have reviewed all patients with a new diagnosis of HNSCC admitted between 2008 and 2014 in “Jorjani Cancer Center”, Tehran, Iran. Overall survival (OS) and event free survival (EFS) of the patients, and their relation with demographic and clinico-pathological factors have been analyzed. RESULTS: Among 119 included patients, 90 were male and 29 were female with mean age of 58 years. Larynx was the most common primary tumor site (55% of all patients). With a median follow-up period of 28 months, OS and EFS of the study patients was 61.2% and 52.4%, respectively. Tumor stage was the only parameter has significantly influenced the patients’ OS. Patients with normal BMIs had significantly higher mean EFS compared with patients with bellow or above normal BMIs. Surgical treatment modalities have resulted in the same prognosis as non-surgical approaches. CONCLUSIONS: Our study seems to be the first that investigated outcome of Iranian patients with head and neck cancer and its influencing factors. Shahid Beheshti University of Medical Sciences 2015-10-27 2015-10 /pmc/articles/PMC4667237/ /pubmed/26634109 http://dx.doi.org/10.17795/ijcp-3842 Text en Copyright © 2015, Iranian Journal of Cancer Prevention. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Novin, Kambiz
Ameri, Ahmad
Faraji, Saba
Torbati, Peyman
Mortazavi, Nafiseh
Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival
title Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival
title_full Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival
title_fullStr Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival
title_full_unstemmed Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival
title_short Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival
title_sort head and neck squamous cell carcinoma in iran: clinico-pathological and treatment-related factors influencing survival
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667237/
https://www.ncbi.nlm.nih.gov/pubmed/26634109
http://dx.doi.org/10.17795/ijcp-3842
work_keys_str_mv AT novinkambiz headandnecksquamouscellcarcinomainiranclinicopathologicalandtreatmentrelatedfactorsinfluencingsurvival
AT ameriahmad headandnecksquamouscellcarcinomainiranclinicopathologicalandtreatmentrelatedfactorsinfluencingsurvival
AT farajisaba headandnecksquamouscellcarcinomainiranclinicopathologicalandtreatmentrelatedfactorsinfluencingsurvival
AT torbatipeyman headandnecksquamouscellcarcinomainiranclinicopathologicalandtreatmentrelatedfactorsinfluencingsurvival
AT mortazavinafiseh headandnecksquamouscellcarcinomainiranclinicopathologicalandtreatmentrelatedfactorsinfluencingsurvival